National Cancer Institute, Italy Report issue

Government Phase 2

Organization Overview

First Clinical Trial
2019
NCT04310176
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

National Cancer Institute, Napoli

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colorectal Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 6